HK1010139A1 - Encapsulated cells producing viral particles. - Google Patents
Encapsulated cells producing viral particles.Info
- Publication number
- HK1010139A1 HK1010139A1 HK98110992A HK98110992A HK1010139A1 HK 1010139 A1 HK1010139 A1 HK 1010139A1 HK 98110992 A HK98110992 A HK 98110992A HK 98110992 A HK98110992 A HK 98110992A HK 1010139 A1 HK1010139 A1 HK 1010139A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- encapsulated cells
- viral particles
- cells producing
- producing viral
- genes
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 3
- 230000003612 virological effect Effects 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 230000001177 retroviral effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK74095 | 1995-06-27 | ||
PCT/EP1996/002748 WO1997001357A1 (en) | 1995-06-27 | 1996-06-24 | Encapsulated cells producing viral particles |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1010139A1 true HK1010139A1 (en) | 1999-06-17 |
Family
ID=8097001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98110992A HK1010139A1 (en) | 1995-06-27 | 1998-09-26 | Encapsulated cells producing viral particles. |
Country Status (22)
Country | Link |
---|---|
US (1) | US6776985B1 (xx) |
EP (1) | EP0835137B1 (xx) |
JP (2) | JP4119952B2 (xx) |
KR (1) | KR100484883B1 (xx) |
CN (1) | CN1187095C (xx) |
AT (1) | ATE309000T1 (xx) |
AU (1) | AU708273B2 (xx) |
CA (1) | CA2222559A1 (xx) |
CZ (1) | CZ286979B6 (xx) |
DE (1) | DE69633180D1 (xx) |
DK (1) | DK0835137T3 (xx) |
ES (1) | ES2253754T3 (xx) |
HK (1) | HK1010139A1 (xx) |
IL (1) | IL122119A (xx) |
NO (1) | NO321427B1 (xx) |
NZ (1) | NZ312671A (xx) |
PL (1) | PL185338B1 (xx) |
PT (1) | PT835137E (xx) |
RU (1) | RU2187301C2 (xx) |
SI (1) | SI0835137T1 (xx) |
UA (1) | UA65525C2 (xx) |
WO (1) | WO1997001357A1 (xx) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5103996A (en) | 1995-03-09 | 1996-10-02 | Bavarian Nordic Research Institute A/S | Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
WO1997001357A1 (en) | 1995-06-27 | 1997-01-16 | Bavarian Nordic Research Institute A/S | Encapsulated cells producing viral particles |
PL188323B1 (pl) | 1996-03-27 | 2005-01-31 | Bavarian Nordic As | Kapsuła zawierająca komórki i jej zastosowanie oraz kompozycja i środek farmaceutyczny |
US6540995B1 (en) | 1996-03-27 | 2003-04-01 | Bavarian Nordic Research Institute Gmbh | Encapsulated cells producing cytochrome P450 |
CN1266362A (zh) | 1998-05-05 | 2000-09-13 | 皇家菲利浦电子有限公司 | 包括具有刷毛区和齿间刷毛区的毛刷件的牙刷 |
CN1950397B (zh) | 2004-03-30 | 2012-05-16 | Ns基因公司 | 生长因子NsG33的治疗用途 |
US20090022785A1 (en) * | 2005-05-03 | 2009-01-22 | Veterinarmedizinische Universitat Wien | Permeable Capsules |
CN101903049B (zh) * | 2007-12-20 | 2014-08-13 | 伊西康公司 | 包囊的肾组织 |
KR101250925B1 (ko) * | 2011-10-28 | 2013-04-04 | 한화케미칼 주식회사 | 캡슐 세포용 구조체 |
GB201408233D0 (en) | 2014-05-09 | 2014-06-25 | Austrianova Singapore Pte Ltd | Use of polyanionic composition |
KR102067352B1 (ko) * | 2015-11-24 | 2020-01-16 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 레트로바이러스 생산을 위한 일시적인 형질감염 방법 |
BR112018010635A2 (pt) * | 2015-11-24 | 2018-11-27 | Glaxosmithkline Ip Dev Ltd | linhagens celulares estáveis para a produção retroviral |
WO2017205573A1 (en) | 2016-05-25 | 2017-11-30 | Lonza Houston Inc. | Methods for isolating adeno-associated virus using a polydiallyldialkylammonium salt |
RU2688383C2 (ru) * | 2017-07-10 | 2019-05-21 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского" | Способ синтеза белка в культуре бактериальных клеток |
CN110615667B (zh) * | 2018-06-19 | 2022-02-15 | 华北理工大学 | 基于铁尾矿和碱渣的核壳结构陶粒及其制备方法 |
JP2024519909A (ja) * | 2021-05-21 | 2024-05-21 | バイオナット ラブス リミテッド | マイクロボット媒介治療送達のためのシステム及び方法 |
CN115820683B (zh) * | 2022-09-28 | 2024-04-05 | 西南大学 | 家蚕Cyp9a20基因及其应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4391909A (en) * | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
DD160393A3 (de) * | 1980-11-14 | 1983-07-27 | Horst Dautzenberg | Mikrokapseln und verfahren zu ihrer herstellung |
US4686098A (en) * | 1984-05-14 | 1987-08-11 | Merck & Co., Inc. | Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo |
US4680174A (en) * | 1984-05-24 | 1987-07-14 | Damon Biotech, Inc. | Induction of immune response by immunization with encapsulated antigen-producing cells |
EP0199362A3 (en) * | 1985-04-26 | 1987-10-07 | Massachusetts Institute Of Technology | System and apparatus for delayed and pulsed release of biologically active substances |
CA1310924C (en) * | 1986-04-24 | 1992-12-01 | Francis P. Mccormick | Infective drug delivery system |
EP0371119B1 (en) | 1988-05-17 | 1996-09-04 | Sloan-Kettering Institute For Cancer Research | Retroviral vector |
US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
DE4021050A1 (de) * | 1990-06-29 | 1992-01-02 | Akad Wissenschaften Ddr | Verfahren zur herstellung von mikrokapseln |
CA2051288C (en) * | 1990-09-14 | 2002-02-05 | Robert L. Martuza | Viral targeted destruction of neoplastic cells |
JPH06500927A (ja) * | 1990-12-13 | 1994-01-27 | アメリカ合衆国 | 高力価の組換えウイルスベクターおよび遺伝子療法に用いられる形質導入標的細胞の持続的及び連続的生産 |
WO1994029437A1 (en) | 1993-06-07 | 1994-12-22 | University Of Medicine & Dentistry Of New Jersey | Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors |
US5688773A (en) | 1994-08-17 | 1997-11-18 | The General Hospital Corporation | Method of selectively destroying neoplastic cells |
HU221607B (hu) | 1994-09-02 | 2002-11-28 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH. | Önmagukat nem inaktiváló, célzott expressziót biztosító retrovírusvektorok |
WO1997001357A1 (en) | 1995-06-27 | 1997-01-16 | Bavarian Nordic Research Institute A/S | Encapsulated cells producing viral particles |
ES2174103T3 (es) | 1995-09-06 | 2002-11-01 | Austrian Nordic Biotherapeutic | Uso de las secuencias reguladoras de wap o mmtv para expresion dirigida de genes heterologos ligados en celulas mamarias humanas, con inclusion de celulas de carcinoma mamario humano. |
PL188323B1 (pl) | 1996-03-27 | 2005-01-31 | Bavarian Nordic As | Kapsuła zawierająca komórki i jej zastosowanie oraz kompozycja i środek farmaceutyczny |
-
1996
- 1996-06-24 WO PCT/EP1996/002748 patent/WO1997001357A1/en active IP Right Grant
- 1996-06-24 KR KR1019970709807A patent/KR100484883B1/ko not_active IP Right Cessation
- 1996-06-24 JP JP50416597A patent/JP4119952B2/ja not_active Expired - Lifetime
- 1996-06-24 RU RU98101362/13A patent/RU2187301C2/ru not_active IP Right Cessation
- 1996-06-24 NZ NZ312671A patent/NZ312671A/xx not_active IP Right Cessation
- 1996-06-24 DK DK96923905T patent/DK0835137T3/da active
- 1996-06-24 CZ CZ19974195A patent/CZ286979B6/cs not_active IP Right Cessation
- 1996-06-24 CN CNB961950501A patent/CN1187095C/zh not_active Expired - Fee Related
- 1996-06-24 PL PL96324289A patent/PL185338B1/pl not_active IP Right Cessation
- 1996-06-24 IL IL12211996A patent/IL122119A/en not_active IP Right Cessation
- 1996-06-24 AT AT96923905T patent/ATE309000T1/de not_active IP Right Cessation
- 1996-06-24 ES ES96923905T patent/ES2253754T3/es not_active Expired - Lifetime
- 1996-06-24 AU AU64154/96A patent/AU708273B2/en not_active Expired
- 1996-06-24 UA UA97126354A patent/UA65525C2/uk unknown
- 1996-06-24 CA CA002222559A patent/CA2222559A1/en not_active Abandoned
- 1996-06-24 DE DE69633180T patent/DE69633180D1/de not_active Expired - Lifetime
- 1996-06-24 PT PT96923905T patent/PT835137E/pt unknown
- 1996-06-24 EP EP96923905A patent/EP0835137B1/en not_active Expired - Lifetime
- 1996-06-24 SI SI9630729T patent/SI0835137T1/sl unknown
-
1997
- 1997-12-10 NO NO19975813A patent/NO321427B1/no not_active IP Right Cessation
- 1997-12-23 US US08/996,460 patent/US6776985B1/en not_active Expired - Lifetime
-
1998
- 1998-09-26 HK HK98110992A patent/HK1010139A1/xx not_active IP Right Cessation
-
2007
- 2007-11-21 JP JP2007301109A patent/JP4848348B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1189104A (zh) | 1998-07-29 |
WO1997001357A1 (en) | 1997-01-16 |
NO975813D0 (no) | 1997-12-10 |
AU708273B2 (en) | 1999-07-29 |
RU2187301C2 (ru) | 2002-08-20 |
DE69633180D1 (de) | 2004-09-23 |
CZ286979B6 (en) | 2000-08-16 |
UA65525C2 (en) | 2004-04-15 |
KR19990028491A (ko) | 1999-04-15 |
AU6415496A (en) | 1997-01-30 |
DK0835137T3 (da) | 2006-03-06 |
IL122119A0 (en) | 1998-04-05 |
PT835137E (pt) | 2004-12-31 |
NO975813L (no) | 1998-02-23 |
PL185338B1 (pl) | 2003-04-30 |
JP4848348B2 (ja) | 2011-12-28 |
EP0835137A1 (en) | 1998-04-15 |
CZ419597A3 (cs) | 1998-03-18 |
NZ312671A (en) | 1999-10-28 |
NO321427B1 (no) | 2006-05-08 |
KR100484883B1 (ko) | 2005-09-02 |
PL324289A1 (en) | 1998-05-11 |
US6776985B1 (en) | 2004-08-17 |
ATE309000T1 (de) | 2005-11-15 |
JPH11508768A (ja) | 1999-08-03 |
SI0835137T1 (sl) | 2006-04-30 |
JP2008101011A (ja) | 2008-05-01 |
CN1187095C (zh) | 2005-02-02 |
JP4119952B2 (ja) | 2008-07-16 |
ES2253754T3 (es) | 2006-06-01 |
IL122119A (en) | 2004-06-01 |
CA2222559A1 (en) | 1997-01-16 |
EP0835137B1 (en) | 2005-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL122119A0 (en) | Encapsulated cells producing viral particles | |
CA2092195A1 (en) | Retroviral packaging cell line | |
AU6871398A (en) | Method for enhancing expression of a foreign or endogenous gene product in pla nts | |
CA2130454A1 (en) | Production of viral resistant plants via introduction of untranslatable plus sense viral rna | |
CA2182303A1 (fr) | Procede de preparation d'un vecteur viral par recombinaison homologue intermoleculaire | |
KR970700771A (ko) | 비-바이러스 벡터(Non-viral vector) | |
IL123833A0 (en) | Vector and method of use for nucleic acid delivery to non-dividing cells | |
GB9813540D0 (en) | Chemical compounds | |
WO1996019568A3 (en) | Stabilized ribozyme analogs | |
CA2154023A1 (en) | Recombinant infectious non-segmented negative strand rna virus | |
MY116535A (en) | New stable pharmaceutical preparation for producing propellant gas-free aerosols | |
AU6933496A (en) | Antagonists of the oncogenic activity of the MDM2 protein and their use in the treatment of cancers | |
AU1022999A (en) | 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs | |
ZA983851B (en) | Substituted 3,3-diamino-2-propenenitriles their preparation and use | |
WO1990006943A3 (de) | Neue tnf-peptide | |
PL329071A1 (en) | Retroviral vector transducing the p 45 cytochrome gene | |
AU3390995A (en) | Novel implant and novel vector for the treatment of acquired diseases | |
AU4903099A (en) | Targeted integration into chromosomes using retroviral vectors | |
WO1996033282A3 (en) | High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations | |
ZA986336B (en) | Medicaments comprising polyhydroxybutylpyrazines novel polyhydroxybutylpyrazines and their preparation | |
CA2331440A1 (en) | Amphotropic retrovirus packaging cell line, process for its production and use thereof | |
OA09197A (fr) | "Peptides SDK, leur procédé de préparation ainsi que des compositions thérapeutiques en contenant". | |
WO1988004666A3 (en) | Lung cytotoxic peptides | |
PT1173471E (pt) | Análogos de pseudomicinas | |
AU1275095A (en) | Antiviral composition of viral protein trans-dominant variants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHPA | Change of a particular in the register (except of change of ownership) | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110624 |